Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
Titel:
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
Auteur:
Licitra, L. Mesia, R. Rivera, F. Remenár, É. Hitt, R. Erfán, J. Rottey, S. Kawecki, A. Zabolotnyy, D. Benasso, M. Störkel, S. Senger, S. Stroh, C. Vermorken, J.B.